Delivery Order SPE2DB22D1017-SPE2DB25FYRCR
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,412.50 on August 29, 2025, for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,682.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in a 100 ml pack. The contract was competitively awarded without set-aside designation under firm fixed pricing and is scheduled for completion by September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,280.92 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, with an ultimate completion date of October 6, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol medication used primarily for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Epidiolex 100 mg/mL solution in 100 mL packs, with a ceiling value of $1,682.50 and an ultimate completion date of September 8, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $3,365.00 delivery order to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs, with an ultimate completion date of September 5, 2025. This is a firm fixed price, non-set-aside delivery order sourced from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the company's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,365.00 to AmerisourceBergen Drug Corp for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. This firm fixed-price delivery order, awarded on August 29, 2025, is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a non-set-aside competitive award, demonstrating the vendor's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,412.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs, with an ultimate completion date of September 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the vendor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,682.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packaging, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside transaction and leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for Epidiolex 100 mg/ml oral solution with a ceiling value of $1,280.92 and a firm fixed price. This delivery order, valued below $1,300, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The contract is non-set-aside and was competitively awarded, with performance scheduled for completion by...
- The Defense Logistics Agency awarded a $8,412.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in a 100 ml pack, with delivery to the company's corporate office location in Conshohocken, Pennsylvania. The award was made on July 23, 2025, with an ultimate completion date of August 13, 2025, and was not designated as a set-aside contract. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRCRDelivery Order
The Defense Logistics Agency awarded a $1,682.50 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Epidiolex 100 mg/ml solution in a 100 ml pack. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a broad range of medications and medical commodities to federal customers, particularly military and veteran healthcare systems. The company has demonstrated its competitive capability through numerous non-set-aside federal contract awards involving firm fixed pricing arrangements with the Defense Logistics Agency. Epidiolex, a CBD-based epilepsy medication, supports the Defense Health Agency and other government healthcare systems' pharmaceutical needs. The delivery order reflects the company's ongoing role as a critical vendor within the DLA's pharmaceutical supply chain, providing specialized medical products across multiple therapeutic domains to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/17/25 |